POLR3C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.159200E-01
Normal-vs-Stage2
4.705800E-01
Normal-vs-Stage3
9.517800E-02
Normal-vs-Stage4
5.666600E-01
Stage1-vs-Stage2
5.057800E-01
Stage1-vs-Stage3
3.872600E-01
Stage1-vs-Stage4
1.567630E-01
Stage2-vs-Stage3
7.601500E-02
Stage2-vs-Stage4
2.099600E-01
Stage3-vs-Stage4
4.164200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.708800E-01
Normal-vs-AfricanAmerican
6.386200E-01
Normal-vs-Asian
7.958800E-01
Caucasian-vs-AfricanAmerican
7.231900E-02
Caucasian-vs-Asian
2.673600E-01
AfricanAmerican-vs-Asian
4.370200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.661200E-01
Normal-vs-Female
3.949600E-01
Male-vs-Female
8.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.590400E-02
Normal-vs-Age(41-60Yrs)
5.297400E-01
Normal-vs-Age(61-80Yrs)
3.725200E-01
Normal-vs-Age(81-100Yrs)
9.324400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.710000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.200200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.371900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.802200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.077600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.100230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.207800E-01
Normal-vs-Daily Drinker
2.180400E-01
Normal-vs-Weekly Drinker
9.604200E-01
Normal-vs-Occasional Drinker
4.355800E-01
Normal-vs-Social Drinker
3.109600E-01
Non Drinker-vs-Daily Drinker
5.318000E-01
Non Drinker-vs-Weekly Drinker
5.411600E-02
Non Drinker-vs-Occasional Drinker
2.605200E-01
Non Drinker-vs-Social Drinker
5.755800E-01
Daily Drinker-vs-Weekly Drinker
4.280300E-02
Daily Drinker-vs-Occasional Drinker
1.405780E-01
Daily Drinker-vs-Social Drinker
3.293000E-01
Weekly Drinker-vs-Occasional Drinker
3.246800E-01
Weekly Drinker-vs-Social Drinker
2.010800E-01
Occasional Drinker-vs-Social Drinker
6.259600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.074400E-01
Normal-vs-Grade 2
8.032000E-01
Normal-vs-Grade 3
7.822000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.093250E-01
Grade 1-vs-Grade 3
7.443800E-02
Grade 1-vs-Grade 4
8.074400E-01
Grade 2-vs-Grade 3
6.132400E-01
Grade 2-vs-Grade 4
8.032000E-01
Grade 3-vs-Grade 4
7.822000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.085400E-01
Normal-vs-NonDiabetic
4.685000E-01
Diabetic-vs-NonDiabetic
7.149900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.917800E-01
Normal-vs-NoPancreatitis
4.107800E-01
Pancreatitis-vs-NoPancreatitis
5.279400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.527800E-01
Normal-vs-N1
4.070000E-01
N0-vs-N1
6.290600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.967200E-01
Normal-vs-TP53-NonMutant
7.063200E-01
TP53-Mutant-vs-TP53-NonMutant
7.543000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
